Name

Innatoss Laboratories BV

Legal name

Innatoss Laboratories BV

Website

https://innatoss.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Innatoss Laboratories is a Dutch ISO/IEC 17025-accredited diagnostic laboratory specializing in multi-test Lyme disease screening, serving Dutch municipalities, water boards, nature organizations, and consumers via its Jaarlijkse Lyme Screening program and LymePaspoort consumer product.

Ownership category

akta.pro rank

Product category

Diagnostic laboratory services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Occupational Health & Employer Testing Laboratories (HLAFAMAK)

akta.pro secondary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

Keywords

• Lyme disease diagnostics
• Serological testing services
• Occupational health screening
• ELISA laboratory testing
• Tick-borne disease monitoring

Headquarters

HQ city

Oss

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. LymePaspoort (B2C/B2B small): One-time purchase of the LymePaspoort test kit through the Innatoss web shop, including blood draw kit, lab testing with at least 3 ELISAs, secure email results, and phone consultation. Currently temporarily unavailable (expected back September).
2. Jaarlijkse Lyme Screening (Annual Organizational Screening): Annual recurring screening service for organizations with 10+ employees working outdoors. Includes education, on-site blood draws, lab testing, personal results with follow-up, management reporting, and evaluation. Pricing is custom quote-based depending on participant count and number of site visits.
3. Additional disease testing: Add-on testing for related conditions such as Tick-borne encephalitis (TBE), Weil's disease, and vaccinations, offered as supplements to the annual screening program for organizations.
4. COVID-19 and Q-fever research projects: Commissioned research projects (e.g., BREAK COVID for LUMC, Q-fever vaccine studies for international partners) generating revenue through grants and research commissions. Innatoss provides study design support, participant recruitment, blood logistics, and laboratory testing.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Innatoss Laboratories is a Dutch independent diagnostic laboratory that runs serological and cellular immunological tests for infectious diseases, principally Lyme disease. Its two commercial products are the LymePaspoort—an annual Borrelia antibody test kit ordered online and processed in its Oss lab using at least three simultaneous CE-marked ELISAs with confirmatory immunoblot—and the Jaarlijkse Lyme Screening (JLS), an annual on-site screening program for organizations with employees working outdoors, including education, phlebotomy, multi-test ELISA analysis, scientist-reviewed results, secure email delivery, and aggregate management reporting for Risk Inventory & Evaluation (RI&E) compliance under Dutch ARBO law.

Product overview

Innatoss Laboratories is a research-intensive diagnostic laboratory specializing in Lyme disease testing services. The company operates two core testing products: the LymePaspoort for individual consumers, freelancers, and small organizations (ordered online with home blood sampling kit and results via secure email), and the Jaarlijkse Lyme Screening (Annual Lyme Screening) for organizations with 10+ employees working outdoors. Both services use a multi-test approach with at least three simultaneous ELISA tests (Euroimmun Borrelia IgG, Euroimmun Borrelia IgM, and Zeus VlsE1-OspC), with confirmatory immunoblot testing available as an add-on. The company holds ISO/IEC 17025:2017 accreditation and NEN 7510:2024 compliance, working exclusively with CE-marked tests. In addition to testing services, Innatoss conducts extensive research on infectious diseases including Lyme, Q-fever, and COVID-19, with past projects including cPass testing, QuantiFERON SARS-CoV-2 validation, ID-Lyme device development, and the ongoing ESPRIT platform development with University of Twente.

Differentiator

Problem solved

Functional benefit

Brands

• LymePaspoort: Annual Borrelia testing product for individuals and small organizations to detect Lyme infection early.
• Jaarlijkse Lyme Screening

Products and services

• LymePaspoort Annual Borrelia antibody testing service for consumers, freelancers, and small organizations. Customers order online, receive a blood sampling kit, provide a blood sample at a local phlebotomy station, and receive results via secure email with follow-up consultation for abnormal results, including an annual personal baseline (null measurement) for detecting new infections.
• Jaarlijkse Lyme Screening (Annual Lyme Screening) Annual organizational Lyme screening program for employers with 10+ outdoor workers, providing education, on-site blood draws by Innatoss nursing staff, in-lab analysis with at least three CE-marked ELISA tests, scientist-reviewed personal results delivered by secure email, and management reporting for Risk Inventory & Evaluation (RI&E) under Dutch ARBO law, with optional add-ons for TBE, Weil's disease, and vaccinations.
• Teken-toolbox (Tick Toolbox) Educational presentation service (approximately 45 minutes to 1 hour) for employers covering tick prevention, bite prevention, proper tick removal, and Lyme disease symptom recognition, deliverable on-site by Innatoss staff or self-administered by the employer, used to support the Jaarlijkse Lyme Screening program.

Quantifiable outcome

• Over 20,000 Lyme tests conducted per year across organizational and consumer programs
• +3 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

14 partnerships are on record, tiered core and minor.

• Universiteit van Twente (University of Twente)coreStrategic or Co-development PartnerCollaboration on the ESPRIT project to develop a novel Lyme diagnostic platform that not only measures antibodies but also directly detects the presence of Borrelia bacteria. The platform combines technologies from multiple partners. Innatoss contributes expertise, knowledge, and research material including serum samples from the JLS program spanning from shortly after infection to years later.
• Vysens (Hengelo)coreTechnology or IntegrationPartner in the ESPRIT project focusing on antibody analysis, including studying how strongly antibodies bind. This provides additional information about how the immune system responds, which is used to develop a more sensitive Lyme diagnostic.
• OccamDx (formerly ECsens, Enschede)coreTechnology or IntegrationPartner in the ESPRIT project working on techniques to measure bacteria directly. This is a significant challenge specifically for Lyme disease, where bacterial loads are typically very low.
• Stichting IMtestcoreStrategic or Co-development PartnerEarly COVID-19 collaboration with a group of 10 medical students operating a MoLab (mobile lab) across the Netherlands. Innatoss validated available tests and processed and evaluated results professionally. This partnership enabled rapid scaling of COVID-19 antibody testing across the country.
• Massachusetts General Hospital — Vaccin and Immunotherapy Center (Boston, USA)coreStrategic or Co-development PartnerLong-standing collaboration on Q-fever vaccine development. Q-Vaxcelerate project combined Innatoss's experience with cellular tests and Q-fever with the presence of many Q-fever patients in the region. Worked with MGH, Epivax, Yale, Colorado State University, and Oxford University on a next-generation Q-fever vaccine with fewer side effects. Followed by Q-fever vaccine study in Brisbane.
• NPK design (Leiden, Netherlands)minorStrategic or Co-development PartnerPartner in the ID-Lyme project (EU Fast Track to Innovation, 2016) for the design and manufacture of a point-of-care cellular immunity testing device for use at GP offices.
• University of Vienna (Universität Wien, Austria)minorStrategic or Co-development PartnerAcademic partner in the ID-Lyme EU Fast Track to Innovation project for cellular immunity testing device development.
• DIARECT (Freiburg, Germany)minorStrategic or Co-development PartnerPartner in the ID-Lyme EU Fast Track to Innovation project, contributing antigen expertise for the cellular immunity testing device.
• University of Queensland (Australia)coreStrategic or Co-development PartnerInternational partner in the Q-fever vaccine study in Brisbane, investigating immune response and side effects after vaccination with Q-VAX. Follow-up project to Q-Vaxcelerate, also involving Australian Rickettsial Reference Lab and Sullivan Nicolaides Pathology.
• Australian Rickettsial Reference Lab / Sullivan Nicolaides Pathology (Australia)coreStrategic or Co-development PartnerAustralian pathology partners in the Q-fever vaccine study in Brisbane, collaborating with Massachusetts General Hospital and University of Queensland.
• Stichting Tekenbeetziekten (Dutch Tick-Borne Diseases Foundation)coreGTM or Marketing PartnerActive collaboration on awareness campaigns including the annual Week van de Teek (Week of the Tick). Innatoss sponsors the campaign and is present daily at the American schoolbus tour. Shared goal of making the Netherlands more aware of tick and tick-borne disease risks. Foundation manages a tick information route and provides educational materials.
• Lymevereniging (Dutch Lyme Association)coreGTM or Marketing PartnerPatient association partnership for awareness and advocacy. Collaboration on the Week van de Teek campaign and shared mission to improve Lyme disease awareness and patient outcomes in the Netherlands.
• MediSapiens (Finland)minorStrategic or Co-development PartnerEU-funded partnership to develop a novel Lyme borreliosis clinical decision system. Innatoss and MediSapiens received EU grant to personalize Lyme diagnostics using computational methods.
• Treeport (West-Brabant tree nursery cooperative)minorGTM or Marketing PartnerCooperative association of ~180 tree nurseries in West-Brabant. Innatoss presented at Treeport Café to introduce Lyme screening to the tree nursery sector, which previously had no formal tick exposure assessment. Potential future collaboration on screening and research.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Bio-Rad Laboratories: Global manufacturer of ELISA platforms, immunoassay reagents, and quality controls used in clinical laboratories. Comparable as a supplier of testing infrastructure and a potential competitor if Bio-Rad expands Lyme diagnostic kits or automated serology platforms.
• Qiagen: Global molecular diagnostics and sample-preparation technology provider whose QuantiFERON SARS-CoV-2 cellular immunity test was validated by Innatoss in 2021. Comparable as a potential partner or competitor in cellular immunity assays and Lyme/COVID diagnostics.
• Cerba Healthcare: International clinical laboratory group with strong presence in specialty and esoteric diagnostics across Europe. Comparable as a potential competitor or commercialization partner for Innatoss's Lyme serology platform and ESPRIT direct-detection assay.
• Synlab: Europe's largest medical diagnostics services provider operating across clinical chemistry, immunology, and specialty testing. Comparable as a potential competitor in occupational health screening programs and a partner candidate for expanding Innatoss's Lyme services into additional European markets.
• Unilabs: One of Europe's largest clinical laboratory networks offering a broad menu of diagnostic tests across multiple specialties. Innatoss already partners with Unilabs Medlon/SHO for blood draw station services; Unilabs represents the kind of scaled incumbent that could compete on Lyme serology with greater geographic reach and lower unit costs.
• QuidelOrtho: Former partner on the Sofia-2 Lyme Plus point-of-care test that Innatoss helped adapt for European Borrelia variants. Comparable as a diagnostic platform incumbent whose withdrawal from European Lyme demonstrates the competitive dynamics of platform-based Lyme testing.

Direct peers

• Star-SHL: Dutch specialty diagnostics laboratory operating a national network focused on blood-based testing and screening services. Comparable as a direct Dutch competitor for occupational screening contracts and a blood draw station partner listed in Innatoss's network.
• SALTRO: Dutch regional clinical diagnostics provider offering laboratory testing, occupational health screening, and preventive services to employers and healthcare providers. Comparable as a direct competitor in the Dutch organizational screening and occupational health market.

Others

• Euroimmun: Manufacturer of CE-marked ELISA test kits including the Borrelia IgG and IgM assays that Innatoss uses as part of its ≥3-ELISA panel. Comparable as a key upstream technology partner and potential competitor if Euroimmun bundles similar multi-test panels for other clinical labs.

Emerging players

• Oxford Immunotec: Specialty diagnostics company focused on tick-borne and infectious disease cellular immunity testing (T-SPOT technology). Comparable as an emerging competitor in the cellular immunity testing space, particularly relevant given Innatoss's patented WOLF point-of-care device and Q-Vaxcelerate work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innatoss Laboratories BV